BinaxNOW® S. aureus

Posted by admin on March 27th, 2014

1

Staphylococcus aureus is a leading cause of invasive bloodstream infection across the world. Inappropriate empirical treatment of infection is associated with increased healthcare costs, morbidity, and mortality.

The BinaxNOW® Staphylococcus aureus Test is a qualitative, in vitro immunochromatographic assay for the presumptive identification of Staphylococcus aureus. The test is performed directly on blood culture samples positive for Gram-positive cocci in clusters.

Product exclusively available for export to select markets.

SKU: 800-000 Categories: ,

Description

Benefits

  • Rapid: The BinaxNOW® S. aureus Test produces easily interpreted results in 30 minutes, 18 to 24 hours sooner than traditional techniques.
  • Unique: BinaxNOW® S. aureus is the first rapid test for samples direct from blood culture. All reagents needed to run assay are contained in the kit.
  • Staphylococcus aureus, a Gram-positive, coagulase-positive bacteria, is a major cause of infection in both healthcare and community settings. Staphylococcus aureus is the leading cause of nosocomial bloodstream infections1 and over half of all sepsis cases are estimated to be caused by Gram-positive cocci in clusters (GPCC) bacteria.2

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Inf Dis. 2004;39:309-317.

2. Martin, Greg S., Mannino, David M., Eaton, Stephanie, Moss, Marc. The Epidemiology of Sepsis in the United States from 1979 through 2000. N Engl J Med 2003: 348: 1546-1554.

Specifications

  • Overall Sensitivity: 93.3%
  • Overall Specificity: 99.6%
  • CPT code 87147
  • Part number: 801-000  22 Test

Kits contain:

  • 22 Test Cards
  • Product Insert
  • Procedure Card

The BinaxNOW® Staphylococcus aureus Test is not intended to diagnose Staphylococcus aureus nor to guide or monitor treatment for Staphylococcus aureus infections. Subculturing positive blood cultures is necessary to recover organisms for susceptibility testing and/or differentiation of mixed growth.